Gail H. Moore
Medical College of Wisconsin
9 Papers
44 Citations
Gail H. Moore is an academic researcher from Medical College of Wisconsin. The author has contributed to research in topics: Transplantation & Axon. The author has an hindex of 7, co-authored 9 publications.
Chat about Author
Papers
Small bowel transplantation promotes bacterial overgrowth and translocation
Barry J. Browne,Christopher P. Johnson,Charles E. Edmiston,Mark A. Hlava,Gail H. Moore,Allan M. Roza,Gordon L. Telford,Mark B. Adams +7 more
TL;DR: Intestinal transplantation alone appears to promote gram-negative overgrowth while the addition of CsA therapy facilitates translocation to the mesenteric lymph nodes and may predispose to gut-associated sepsis following SBT.
31
Effects of axotomy on the cholinesterase and carbonic anhydrase activities of axons in the proximal and distal stumps of rabbit sciatic nerves: a temporal study.
TL;DR: Histochemical axon typing indicated that sensory axons regenerated earlier and to a greater degree than motor axons in the developing neuroma, implying that these techniques may aid in both immediate and delayed primary nerve repair.
19
Untreated diabetes mellitus promotes intestinal microbial overgrowth.
Allan M. Roza,Charles E. Edmiston,Constantine T. Frantzides,Gail H. Moore,Thomas V. Nowak,Christopher P. Johnson,Mark B. Adams +6 more
TL;DR: It is suggested that sustained normalization of glucose levels is not required to prevent microbial overgrowth in diabetic rats, and insulin treatment and pancreatic transplantation prevented microbial over growth in the diabetic small intestine.
17
Small bowel transplantation in the rat with immediate restoration of intestinal continuity
TL;DR: A two‐stage technique of SBT in the rat is described that minimizes perioperative complications and also allows immediate restoration of intestinal continuity and results in consistently improved survival and minimal morbidity.
11
•Journal Article
Tulopafant, a PAF receptor antagonist, increases capillary patency and prolongs survival in discordant cardiac xenotransplants.
Daniel O'Hair,Allan M. Roza,Richard A. Komorowski,Gail H. Moore,R P McManus,Christopher P. Johnson,Mark B. Adams,Galen M. Pieper +7 more
TL;DR: This study provides the first known evidence of the efficacy of the PAF receptor antagonist, tulopafant, in improvement in graft function and histology of discordant cardiac xenografts.
9